Physician profile
Bassel Jallad
NPI 1124282306
$1,018.51
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2021: $300.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $300.00 | 2021 | |
| Janssen Biotech, INC. | $128.40 | 2019 | |
| Amgen INC. | $94.30 | 2019 | |
| Novo Nordisk INC | $57.03 | 2019 | |
| Merck Sharp & Dohme LLC | $49.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $45.36 | 2019 | |
| Janssen Scientific Affairs, LLC | $36.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $35.59 | 2019 | |
| Taiho Oncology, INC. | $28.24 | 2019 | |
| Pfizer INC. | $28.15 | 2019 | |
| Celgene Corporation | $21.40 | 2019 | |
| Astellas Pharma US INC | $20.52 | 2019 | |
| Genzyme Corporation | $19.84 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.64 | 2019 | |
| Lilly USA, LLC | $18.27 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $17.32 | 2019 | |
| Exelixis INC. | $15.44 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $14.40 | 2019 | |
| Incyte Corporation | $14.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.25 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.78 | 2019 | |
| Agios Pharmaceuticals, INC. | $11.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassel Jallad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.